Background
Sepsis, caused by a dysregulated response to infections, can lead to cardiac arrhythmias. However, the mechanisms underlying sepsis‐induced inflammation, and how inflammation provokes cardiac arrhythmias, are not well understood. We hypothesized that cannabidiol (CBD) may ameliorate lipopolysaccharide (LPS)‐induced cardiotoxicity, via Toll‐like receptors (TLR4) and cardiac sodium channels (NaV1.5).
Methods and results
We incubated human immune cells (THP‐1 macrophages) with LPS for 24 h, then extracted the THP‐1 incubation media. ELISA assays showed that LPS (1 or 5 μg·ml−1), in a concentration‐dependent manner, or MPLA (TLR4 agonist, 5 μg·ml−1) stimulated the THP‐1 cells to release inflammatory cytokines (TNF‐α and IL‐6). Prior incubation (4 h) with CBD (5 μM) or C34 (TLR4 antagonist: 5 μg·ml−1) inhibited LPS and MPLA‐induced release of both IL‐6 and TNF‐α. Human‐induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CM) were subsequently incubated for 24 h in the media extracted from THP‐1 cells incubated with LPS, MPLA alone, or in combination with CBD or C34. Voltage‐clamp experiments showed a right shift in the voltage dependence of NaV1.5 activation, steady state fast inactivation (SSFI), increased persistent current and prolonged in silico action potential duration in hiSPC‐CMs incubated in the LPS or MPLA‐THP‐1 media. Co‐incubation with CBD or C34 rescued the biophysical dysfunction caused by LPS and MPLA.
Conclusion
Our results suggest that CBD may protect against sepsis‐induced inflammation and subsequent arrhythmias through (i) inhibition of the release of inflammatory cytokines, antioxidant and anti‐apoptotic effects and/or (ii) a direct effect on NaV1.5.